EVERSEPT PARTNERS, LP – Celldex Therapeutics, Inc. Transaction History
EVERSEPT PARTNERS, LP portfolio value:
$17.60M
portfolio value
EVERSEPT PARTNERS, LP quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +13.39% | 73.98K shares | 2.71M | $28.11 | 626.37K |
| Q2 2022 | share | Decrease | -13.21% | -84.06K shares | -6.78M | $26.96 | 552.38K |
| Q1 2022 | share | Increase | +7.42% | 43.97K shares | -1.21M | $34.06 | 636.45K |
| Q4 2021 | share | Increase | 0.00% | 592.47K shares | 22.89M | $38.9 | 592.47K |
| Q4 2020 | share | Decrease | -100.00% | -150.49K shares | -2.23M | $17.52 | 0 |
| Q3 2020 | share | Decrease | -78.88% | -562.20K shares | -7.03M | $14.83 | 150.49K |
| Q2 2020 | share | Increase | 0.00% | 712.69K shares | 9.26M | $13 | 712.69K |